Go Pro

Marsh & McLennan Companies (NYSE:MRSH) Stock Price Expected to Rise, UBS Group Analyst Says

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • UBS Group raised its price target for Marsh & McLennan Companies to $216 from $212 and maintained a “buy” rating, implying 17.26% upside from the prior close. However, the broader analyst consensus remains “hold,” with an average target of $201.94.
  • MRSH shares rose 1.9% to $184.21, while the company’s latest earnings exceeded expectations: adjusted EPS was $2.96 versus a $2.89 consensus estimate, and quarterly revenue increased 6.2% year over year to $7.28 billion.
  • Institutional investors own nearly 88% of the stock, with several funds increasing their positions recently. CEO John Q. Doyle sold 16,656 shares under a pre-arranged trading plan, reducing his holdings by 12.48%.
  • Five stocks to consider instead of Marsh & McLennan Companies.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) had its price objective lifted by stock analysts at UBS Group from $212.00 to $216.00 in a report released on Monday,Benzinga reports. The brokerage currently has a "buy" rating on the financial services provider's stock. UBS Group's target price points to a potential upside of 17.26% from the company's previous close.

A number of other equities research analysts have also weighed in on the stock. Barclays dropped their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating on the stock in a report on Wednesday, April 8th. Morgan Stanley lowered their price objective on Marsh & McLennan Companies from $180.00 to $175.00 and set an "equal weight" rating on the stock in a research report on Monday, July 6th. Keefe, Bruyette & Woods raised their target price on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a "market perform" rating in a research report on Friday, April 17th. Piper Sandler reduced their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating for the company in a research report on Tuesday, May 26th. Finally, Mizuho lifted their price target on Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $201.94.

Get Our Latest Analysis on Marsh & McLennan Companies

Marsh & McLennan Companies Trading Up 1.9%

NYSE:MRSH traded up $3.47 during midday trading on Monday, reaching $184.21. 956,116 shares of the stock traded hands, compared to its average volume of 2,920,375. The stock has a market capitalization of $87.91 billion, a price-to-earnings ratio of 22.53, a PEG ratio of 2.60 and a beta of 0.61. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. Marsh & McLennan Companies has a 12-month low of $156.60 and a 12-month high of $213.80.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.89 by $0.07. The firm had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The business's revenue for the quarter was up 6.2% on a year-over-year basis. As a group, sell-side analysts anticipate that Marsh & McLennan Companies will post 10.41 earnings per share for the current fiscal year.

Insider Activity

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer owned 116,811 shares of the company's stock, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in MRSH. Family Wealth Partners LLC purchased a new position in shares of Marsh & McLennan Companies during the 2nd quarter valued at $219,000. Tema ETFs LLC grew its position in shares of Marsh & McLennan Companies by 9.5% during the second quarter. Tema ETFs LLC now owns 10,029 shares of the financial services provider's stock worth $1,672,000 after purchasing an additional 870 shares in the last quarter. Handelsbanken Fonder AB boosted its stake in Marsh & McLennan Companies by 7.4% in the 2nd quarter. Handelsbanken Fonder AB now owns 215,758 shares of the financial services provider's stock worth $35,960,000 after purchasing an additional 14,929 shares during the period. Revolve Wealth Partners LLC purchased a new position in shares of Marsh & McLennan Companies in the second quarter worth $372,000. Finally, Franklin Parlapiano Turner & Welch LLC grew its stake in Marsh & McLennan Companies by 4.1% during the second quarter. Franklin Parlapiano Turner & Welch LLC now owns 41,467 shares of the financial services provider's stock valued at $6,911,000 after acquiring an additional 1,643 shares in the last quarter. 87.99% of the stock is owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Company Profile

(Get Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Recommended Stories

Analyst Recommendations for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines